BlackRock Group’s Neurogene NGNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | $3.83M | Hold |
11,600
| – | – | ﹤0.01% | 1325 |
|
|
2016
Q3 | $3.1M | Buy |
11,600
+1,595
| +16% | +$426K | ﹤0.01% | 1340 |
|
|
2016
Q2 | $1.33M | Hold |
10,005
| – | – | ﹤0.01% | 1804 |
|
|
2016
Q1 | $1.77M | Buy |
10,005
+1,895
| +23% | +$334K | ﹤0.01% | 1616 |
|
|
2015
Q4 | $2.02M | Hold |
8,110
| – | – | ﹤0.01% | 1468 |
|
|
2015
Q3 | $2.28M | Buy |
8,110
+5,590
| +222% | +$1.57M | ﹤0.01% | 1412 |
|
|
2015
Q2 | $350K | Hold |
2,520
| – | – | ﹤0.01% | 2378 |
|
|
2015
Q1 | $414K | Buy |
2,520
+80
| +3% | +$13.1K | ﹤0.01% | 2256 |
|
|
2014
Q4 | $366K | Hold |
2,440
| – | – | ﹤0.01% | 2332 |
|
|
2014
Q3 | $325K | Hold |
2,440
| – | – | ﹤0.01% | 2299 |
|
|
2014
Q2 | $460K | Hold |
2,440
| – | – | ﹤0.01% | 2210 |
|
|
2014
Q1 | $621K | Buy |
+2,440
| New | +$621K | ﹤0.01% | 2146 |
|